Risk and Risk Score Performance of Hepatocellular Carcinoma Development in Patients With Hepatitis B Surface Antigen Seroclearance

Hepatocellular carcinoma (HCC) can develop among chronic hepatitis B patients after hepatitis B surface antigen (HBsAg) seroclearance. However, whether HCC risk after HBsAg seroclearance differs between antiviral therapy (AVT)-induced or spontaneous seroclearance cases and ways to identify at-risk p...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Yewan, Lee, Jeong-Hoon, Sinn, Dong Hyun, Park, Jun Yong, Kim, Minseok Albert, Kim, Yoon Jun, Yoon, Jung-Hwan, Kim, Do Young, Ahn, Sang Hoon, Kang, Wonseok, Gwak, Geum-Youn, Paik, Yong-Han, Choi, Moon Seok, Lee, Joon Hyeok, Koh, Kwang Cheol, Paik, Seung Woon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7803670/
https://www.ncbi.nlm.nih.gov/pubmed/33433118
http://dx.doi.org/10.14309/ctg.0000000000000290

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7803670/
https://www.ncbi.nlm.nih.gov/pubmed/33433118
http://dx.doi.org/10.14309/ctg.0000000000000290

Ejemplares similares